// App-Quantinova.ai

OC 52.2 : Risk and impact of anticoagulation-associated abnormal menstrual bleeding in women of reproductive age with venous thromboembolism – the TEAM-VTE study

Researchers

Presenter

  • C. De Jong

Principal Investigators

  • M. Blondon

  • C. Ay

  • J. Beyer Westendorf

  • L. Bertoletti

  • G. Colombo

  • M. Donadini

  • L. Jara-Palomares

  • S. Nopp

  • C. Tromeur

  • T. Vanassche

  • F. Klok

Medical Centers

  • ,Leiden University Medical Center, Leiden, The Netherlands, Leiden, Zuid-Holland, Netherlands

  • Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

  • Dept. of Medicine I, Div. of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

  • Service de Médecine Vasculaire et Thérapeutique, CHU Saint Etienne, Saint-Étienne, Rhone-Alpes, France

  • Department of Medicine, Division Hematology, Dresden University Hospital, Dresden, Sachsen, Germany

  • Department of Oncology and Internal Medicine, Klinik Arlesheim, Arlesheim, Basel-Landschaft, Switzerland

  • CHU Saint Etienne, Saint-Etienne, Rhone-Alpes, France

  • University of Insubria, Varese, Lombardia, Italy

  • Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Varese, Italy, Varese, Lombardia, Italy

  • Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands

  • Medical Surgical Unit of Respiratory Diseases. Hospital Universitario Virgen del Rocio, Sevilla, Spain. Instituto de Biomedicina de Sevilla (IbiS), Sevilla, Spain. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Córdoba, Andalucia, Spain

  • Medical University of Vienna, Vienna, Austria

  • Department of Internal Medicine, Clínica Universidad de Navarra, Madrid, Madrid, Spain

  • Department of Internal Medicine and Chest Diseases, CHU de Brest, Brest, Bretagne, France

  • University Hospitals Leuven, KULeuven, Leuven, Belgium, Leuven, Vlaams-Brabant, Belgium

  • Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands

Locations

  • Netherlands

  • Switzerland

  • Austria

  • France

  • Germany

  • Italy

  • Spain

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A